| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |